These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35931132)

  • 1. Effect of pentaerythritol tetranitrate (PETN) on the development of fetal growth restriction in pregnancies with impaired uteroplacental perfusion at midgestation-a randomized trial.
    Groten T; Lehmann T; Städtler M; Komar M; Winkler JL; Condic M; Strizek B; Seeger S; Jäger Y; Pecks U; Eckmann-Scholz C; Kagan KO; Hoopmann M; von Kaisenberg CS; Brodowski L; Tauscher A; Schrey-Petersen S; Friebe-Hoffmann U; Lato K; Hübener C; Delius M; Verlohren S; Sroka D; Schlembach D; de Vries L; Kraft K; Seliger G; Schleußner E;
    Am J Obstet Gynecol; 2023 Jan; 228(1):84.e1-84.e12. PubMed ID: 35931132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: a prospective, randomized, double-blinded trial.
    Schleussner E; Lehmann T; Kähler C; Schneider U; Schlembach D; Groten T
    J Perinat Med; 2014 Jul; 42(4):507-14. PubMed ID: 24421214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Pentaerytrithyltetranitrate reduce fetal growth restriction in pregnancies complicated by uterine mal-perfusion? Study protocol of the PETN-study: a randomized controlled multicenter-trial.
    Groten T; Lehmann T; Schleußner E;
    BMC Pregnancy Childbirth; 2019 Sep; 19(1):336. PubMed ID: 31521118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentaerythrityl tetranitrate improves the outcome of children born to mothers with compromised uterine perfusion-12-months follow-up and safety data of the double-blind randomized PETN trial.
    Groten T; Lehmann T; Städtler M; Komar M; Winkler JL; Condic M; Strizek B; Seeger S; Jäger Y; Pecks U; Eckmann-Scholz C; Kagan KO; Hoopmann M; von Kaisenberg CS; Hertel B; Tauscher A; Schrey-Petersen S; Friebe-Hoffmann U; Lato K; Hübener C; Delius M; Verlohren S; Sroka D; Schlembach D; de Vries L; Kraft K; Seliger G; Schleußner E;
    Am J Obstet Gynecol MFM; 2024 Apr; 6(4):101332. PubMed ID: 38460823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentaerythrityltetranitrate (PETN) improves utero- and feto-placental Doppler parameters in pregnancies with impaired utero-placental perfusion in mid-gestation - a secondary analysis of the PETN-pilot trial.
    Bowkalow S; Schleussner E; Kähler C; Schneider U; Lehmann T; Groten T
    J Perinat Med; 2018 Nov; 46(9):1004-1009. PubMed ID: 29272253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial.
    Pels A; Derks J; Elvan-Taspinar A; van Drongelen J; de Boer M; Duvekot H; van Laar J; van Eyck J; Al-Nasiry S; Sueters M; Post M; Onland W; van Wassenaer-Leemhuis A; Naaktgeboren C; Jakobsen JC; Gluud C; Duijnhoven RG; Lely T; Gordijn S; Ganzevoort W;
    JAMA Netw Open; 2020 Jun; 3(6):e205323. PubMed ID: 32585017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using ultrasound and angiogenic markers from a 19- to 23-week assessment to inform the subsequent diagnosis of preeclampsia.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2022 Aug; 227(2):294.e1-294.e11. PubMed ID: 35276067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal treatment of spontaneously hypertensive rats with pentaerythritol tetranitrate reduces blood pressure in female offspring.
    Wu Z; Siuda D; Xia N; Reifenberg G; Daiber A; Münzel T; Förstermann U; Li H
    Hypertension; 2015 Jan; 65(1):232-7. PubMed ID: 25385760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
    Groom KM; David AL
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial.
    Rehal A; Benkő Z; De Paco Matallana C; Syngelaki A; Janga D; Cicero S; Akolekar R; Singh M; Chaveeva P; Burgos J; Molina FS; Savvidou M; De La Calle M; Persico N; Quezada Rojas MS; Sau A; Greco E; O'Gorman N; Plasencia W; Pereira S; Jani JC; Valino N; Del Mar Gil M; Maclagan K; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2021 Jan; 224(1):86.e1-86.e19. PubMed ID: 32598909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OS013. Reduction of preeclampsia related complications with with theNO-donor penterythriltetranitrat (petn) in risk pregnancies - Aprospective randomized double-blind placebo pilot study.
    Groten T; Fitzgerald J; Lehmann T; Schneider U; Kähler C; Schleussner E
    Pregnancy Hypertens; 2012 Jul; 2(3):181. PubMed ID: 26105227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pravastatin plus L-arginine prevents adverse pregnancy outcomes in women with uteroplacental vascular dysfunction.
    Jurisic A; Jurisic Z; Lefkou E; Girardi G
    Vascul Pharmacol; 2021 Apr; 137():106824. PubMed ID: 33249273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of biochemical tests of placental function for improving pregnancy outcome.
    Heazell AE; Whitworth M; Duley L; Thornton JG
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011202. PubMed ID: 26602956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental pulsatility index: a new, more sensitive parameter for predicting adverse outcome in pregnancies suspected of fetal growth restriction.
    Gudmundsson S; Flo K; Ghosh G; Wilsgaard T; Acharya G
    Acta Obstet Gynecol Scand; 2017 Feb; 96(2):216-222. PubMed ID: 27858967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of serial circulating placental growth factor levels and uterine artery Doppler waveforms in diagnosing underlying placental diseases in pregnancies at high risk of placental dysfunction.
    Agrawal S; Parks WT; Zeng HD; Ravichandran A; Ashwal E; Windrim RC; Hobson SR; Melamed N; Kingdom JC
    Am J Obstet Gynecol; 2022 Oct; 227(4):618.e1-618.e16. PubMed ID: 35644246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia.
    Kovo M; Schreiber L; Elyashiv O; Ben-Haroush A; Abraham G; Bar J
    Reprod Sci; 2015 Mar; 22(3):316-21. PubMed ID: 25001023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OP002. Impact of the NO-donor pentaerythrithyltetranitrate on perinatal outcome in high-risk pregnancies: A prospective randomized double blinded pilot study.
    Dietmar S; Tanja G; Thomas L; Uwe S; Ekkehard S
    Pregnancy Hypertens; 2013 Apr; 3(2):62. PubMed ID: 26105847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.
    Boutin A; Guerby P; Gasse C; Tapp S; Bujold E
    Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal and fetal vascular lesions of malperfusion in the placentas associated with fetal and neonatal death: results of a prospective observational study.
    Kulkarni VG; Sunilkumar KB; Nagaraj TS; Uddin Z; Ahmed I; Hwang K; Goudar SS; Guruprasad G; Saleem S; Tikmani SS; Dhaded SM; Yogeshkumar S; Somannavar MS; McClure EM; Goldenberg RL
    Am J Obstet Gynecol; 2021 Dec; 225(6):660.e1-660.e12. PubMed ID: 34111407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.